Grifols Therapeutics LLC

Clayton, NC Grifols Therapeutics LLC

UEI
UFQ3A7GKJ5C7
CAGE
6SLC6
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
8368 Clayton Blvd, Clayton, NC 27520, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Grifols Therapeutics LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Grifols therapeutics LLC- ocular surface immunoglobulin in the management of vesicant agents injury Contract · 75A50124C00050 Office of the Assistant Secretary for Preparedness and Response $613,200
Prolastin-c Contract · 36C26022F0140 Veterans Integrated Service Network 20 $100,282
Prolastin c Contract · 36C26022F0004 Veterans Integrated Service Network 20 $454,461
Prolastin 1000MG/vial Contract · 36C26021F0264 Veterans Integrated Service Network 20 $130,406
Prolastin Contract · 36C26021F0117 Veterans Integrated Service Network 20 $75,000

About Grifols Therapeutics LLC

Grifols Therapeutics LLC is a for-profit corporate entity registered in the System for Award Management (SAM), headquartered in Durham, North Carolina. The company is a manufacturer of pharmaceuticals and biopharmaceuticals, specializing in producing medical products such as immunoglobulins, respiratory therapeutics, and specialized medical treatments. As a limited liability company with a robust federal contracting presence, Grifols has established itself as a key supplier to various federal agencies, demonstrating consistent capability in delivering medical and pharmaceutical products through government contract vehicles.

The federal contract awards for Grifols Therapeutics LLC primarily focus on pharmaceutical product deliveries, with a significant concentration of contracts from the Department of Veterans Affairs (VA) Veterans Health Administration. The company has consistently provided products like PROLASTIN, PROLASTIN-C, and immune globulin through delivery orders under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). These contracts, ranging from $1,314.80 to $454,461.44, have not utilized small business set-asides. Additionally, Grifols has secured a notable contract with the Office of the Assistant Secretary for Preparedness and Response for ocular surface immunoglobulin to manage injuries from vesicant agents, valued at $613,200.00. The contract awards demonstrate the company's expertise in supplying specialized medical treatments and pharmaceuticals to federal agencies, with a track record of delivering high-value, mission-critical medical products across different government sectors.

Contract vehicles

Quick answers

What is Grifols Therapeutics LLC's UEI?

Grifols Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is UFQ3A7GKJ5C7.

What is Grifols Therapeutics LLC's CAGE code?

Grifols Therapeutics LLC's CAGE code is 6SLC6.

What is Grifols Therapeutics LLC's primary NAICS code?

Grifols Therapeutics LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Grifols Therapeutics LLC located?

Grifols Therapeutics LLC's physical address in SAM.gov is 8368 Clayton Blvd, Clayton, NC 27520, USA.

Is Grifols Therapeutics LLC registered in SAM.gov?

Yes. Grifols Therapeutics LLC's SAM.gov registration is active through April 22, 2027.

Which contract vehicles does Grifols Therapeutics LLC hold?

Grifols Therapeutics LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Grifols Therapeutics LLC's most recent federal award?

Grifols Therapeutics LLC's most recent federal contract award is Grifols therapeutics LLC- ocular surface immunoglobulin in the management of vesicant agents injury (75A50124C00050), from Office of the Assistant Secretary for Preparedness and Response, on September 27, 2024.

On GovTribe

See Grifols Therapeutics LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors